
JAMA Internal Medicine : Azelastine Nasal Spray for Prevention of SARS-CoV-2 Infections
JAMA Network
00:00
Exploring the Potential of Azelastine Nasal Spray Against COVID-19
This chapter reviews the results of a phase two study on the efficacy of azelastine nasal spray in preventing SARS-CoV-2 infections, indicating its potential as an antiviral treatment. It highlights the necessity for additional research, especially a phase three trial to assess its impact on at-risk populations and examines the implications of its mechanism of action.
Transcript
Play full episode